Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Isodeoxyelephantopin
Cat. No.:
OB0225LY-0397
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Isodeoxyelephantopin is a small molecule compound with the ability to inhibit tumor growth.
Synonym:
38927-54-7; Deoxyelephantopin; [(3S,4R,8R,9E,12R)-10-Methyl-5-methylidene-6,14-dioxo-7,13-dioxatricyclo[10.2.1.04,8]pentadeca-1(15),9-dien-3-yl] 2-methylprop-2-enoate
CAS No.:
38927-54-7
Compound CID:
6325056
Formula:
C19H20O6
Formula Weight:
344.36
Specification
Relative Density:
1.26 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Isodeoxyelephantopin can be used to explore its role in biological mechanisms such as anti-tumor, anti-inflammatory, and anti-oxidant.
Library Information
Targets:
Reactive oxygen species; NF-κB
Pathways:
Autophagy; Metabolism; NF-κB; Immunology/Inflammation
Plate Number:
AOCL-6
Plate Location:
b3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 159.72 mM
